New Drug: Tepotinib for NSCLC with MET Exon14 skipping mutations
|New Drug: Tepotinib for NSCLC with MET Exon14 skipping mutations|
• Open-label phase II trial (VISION)
N Engl J Med. Published online May 29, 2020
Reviewed by Ulas Darda Bayraktar, MD on Feb 6, 2021
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.